Abba Medix Group to Present at Canada Cannabis Conference Held by Jacob Securities

Abba Medix Group Is a Sponsor and Presenter at Jacob Securities' Canada Cannabis Conference on June 22nd in Toronto

June 22, 2015 7:00 AM EDT | Source: Canada House Cannabis Group Inc.

Toronto, Ontario--(Newsfile Corp. - June 22, 2015) - Abba Medix Group Inc. (CSE: ABA) is pleased to announce it will be a sponsor and presenter at the Canada Cannabis Conference, hosted by Jacob Securities Inc., on June 22, 2015 at the Trump Hotel, Toronto. Ray Rasouli, CEO, will present on behalf of Abba Medix.

Abba will be discussing the Next Big Wave and the future of the Canadian marijuana industry. Topics will include Abba's growing business lines including the previously announced agreement to acquire RedeCan Pharm, which is an Ontario based licensed producer and distributor of medical marijuana, and Blow Vapor, a leading vaporizer and accessory company. Mr. Ray Rasouli, the CEO of Abba will represent the Company on a panel of recent MMPR license winners who will be discussing their unique approaches to the Canadian MMPR program after observing the efforts of Health Canada and previous license winners. In addition, Abba will be featuring their vision for the future positioning of the legalization of new marijuana delivery systems, vapor delivery, the challenge of edibles and infusions, cross-border investing and trading, industry consolidation, patient intake initiatives, and research and development. Mr. Rasouli will also be taking one-on-one meetings between company representatives and attendees.

Canada Cannabis Conference Event Details:

June 22, 2015
7:30 am — 4:30 pm EST
Trump Hotel
Grand Ballroom
325 Bay Street
Toronto, ON M5H 4G3

About the Canada Cannabis Conference
The Canada Cannabis Conference will be the first investor conference held in the country and will feature management teams from licensed producers and leading industry experts. Topics will be tailored to properly equip interested investors with the ability to make informed decisions and will include: the current state of the industry, what to expect over the next twenty-four months, impact of recent court cases, industry consolidation, and the constantly changing supply/demand balance in the MMPR program.

For more information regarding the Conference, please visit www.jacobsecurities.com/conference, or RSVP to Alyssa Wilkinson at awilkinson@jacobsecurities.com.

About Jacob Securities Inc. (JSI)
Jacob Securities is Canada's leading independent investment dealer focused on renewable energy, clean technology and the medical marijuana sector. Based in Toronto, JSI has completed more transactions in the renewable energy and medical marijuana sectors than any other investment dealer in Canada. JSI has participated in transactions valued in excess of $7 billion for renewable power projects since 2006 and raised over $70 million for public and private cannabis companies since 2014. For more information please visit www.jacobsecurities.com.

About Abba Medix Group
Abba Medix Group Inc. (CSE:ABA) is a purveyor of fine Canadian medical marijuana, accessories, events, and news. The Company is becoming a marketplace leader through strategic partnerships, mergers, and acquisitions to create a fully-integrated, Canadian medical marijuana marketplace. Abba's mission is to find and acquire strong marijuana related businesses, product companies, organizational event sponsorships, and research and development opportunities.

Through the pending acquisition of RedeCan, Abba is a licensed medical marijuana grower and sales agent, authorized to supply Canadian patients.

Through Blow Vapor, Abba is providing customers with nothing but the best, most innovative products on the market, offering a wide collection of premium products to fit everyone's lifestyle and vaping preferences.

For more information on the Abba Medix Group, please visit www.abbamedix.com. To shop RedeCan's medical marijuana strains, visit http://redecanpharm.ca. To shop for the perfect vape at Blow Vapor, visit www.blowvapor.com.

Cautionary Statements Regarding Forward-Looking Information
Certain statements within this press release relating to the Company constitute "forward-looking statements", within the meaning of applicable securities laws, including without limitation, statements regarding future estimates, business plans and / or objectives, sales programs, forecasts and projections, assumptions, expectations, and/or beliefs of future performance, are "forward-looking statements". Such "forward-looking statements" involve known and unknown risks and uncertainties that could cause actual and future events to differ materially from those anticipated in such statements. Forward-looking statements include, but are not limited to, statements with respect to commercial operations, including production and / or sales of medical marijuana, quantities of future medical marijuana production, anticipated revenues in connection with such sales, the overall projected size of the market, completion and / or expansion of production facilities, and other information that is based on forecasts of future results, estimates of production not yet determinable, and other key management assumptions. Actual results may differ materially from those expressed or implied by such forward-looking statements and involve risk and uncertainties relating to the Company's historical experience with regulatory changes, timeliness of government approvals for the granting of permits and licenses, changes in medical marijuana prices, actual operating performance of facilities, and other uninsured risks. The Company assumes no responsibility to update or revise forward-looking information to reflect new events or circumstances unless required by law. Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.

For further information please contact:

Ahmad (Ray) Rasouli
Chief Executive Officer
Abba Medix Group Inc.
Tel: (905) 492-9420

Sasha Jacob
President and CEO
Jacob Securities Inc.
Tel:  (416) 866-8300

info